1. Calcium channel TRPV6 promotes breast cancer metastasis by NFATC2IP
- Author
-
Jun Mi, Jinming Yu, Yugang Wang, Na Li, and Xiang Xu
- Subjects
Cancer Research ,NFATC2 ,TRPV6 ,TRPV Cation Channels ,Breast Neoplasms ,Cell Line ,Metastasis ,Mice ,ADAMTS Proteins ,Breast cancer ,Downregulation and upregulation ,Cell Movement ,Cell Line, Tumor ,medicine ,Animals ,Humans ,Phosphorylation ,skin and connective tissue diseases ,Kinase ,business.industry ,Cyclin-dependent kinase 5 ,Cyclin-Dependent Kinase 5 ,Cell migration ,medicine.disease ,Up-Regulation ,HEK293 Cells ,Oncology ,MCF-7 Cells ,Cancer research ,Female ,Calcium Channels ,Carrier Proteins ,business - Abstract
Calcium channel TRPV6 upregulation is associated with poor prognosis of breast cancer by promoting invasion and metastasis, and TRPV6 is a potential target for breast cancer therapy. However, the mechanism by which TRPV6 promotes breast metastasis remains unclear. Here, we report that TRPV6 expression is upregulated in metastatic breast cancers and that TRPV6 overexpression or upregulation accelerates primary breast cancer cell migration. In contrast, TRPV6 suppression decreases cell migration. Mechanistically, TRPV6 activates NFATC2 by increasing NFATC2IP phosphorylation at Ser204, and CDK5 is a candidate kinase that may perform this phosphorylation. Consequently, activated NFATC2 increases breast cancer metastasis by upregulating ADAMTS6 expression. These observations suggest that TRPV6 increases NFATC2 transcriptional activity by increasing NFATC2IP phosphorylation, which consequently upregulates ADAMTS6 expression to promote breast cancer metastasis.
- Published
- 2021